TAK-659
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for TAK-659, covering 2020-03-31 to 2025-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma [Phase 1]